Curing Cancer by DNA Engineering: The first trial will be next month!

in #science8 years ago

The new genome editing technique CRISPR-Cas9 will be used in human patients for the first time. A Chinese group of scientist have permission to enroll patients with non-small cell lung cancer for whom other treatments have failed. CRISPR-Cas9 will be used to knock out a receptor protein in the immune cells that prevents them from being killed by the cancer cells.

CRISPR/Cas9


For those who are not familiar with the technique. CRISPR/Cas9 has made a huge impact in the field of DNA engineering. The technique is making it possible to introduce very precise cuts in the DNA of a living organism. At the location of the cut, researchers have been able successfully introduced new DNA code. But in most cases they left the cut to be repaired by a cell repair mechanisms, which led to "broken DNA code" which no longer leads to an effective protein. Disabling a protein can have many uses in biotechnology. The ease of use makes this technique very effective and used throughout all fields of biotechnology, now including healthcare.

PD-1 and Lung Cancer


So PD-1 is a receptor protein expressed on the membrane of certain immune cells (T cells). If the receptor is triggered by it's ligand (PD-L1), the T cell dies (apoptosis). You can effectively call it a death switch. This death-switch is there to prevent autoimmune reactions. Cells from your body express PD-L1 to prevent being attacked. The problem with cancers however is, that they are highly expressing this PD-L1 ligand, and are so immune to the attacks from T-cells. Pharmaceutical companies have tried to make molecules that block the receptor or the ligand, to prevent interaction, but the success rate highly varies between patients.

The First CRISPR/Cas9 Trial


To fight the cancer, the interaction between the PD-1 receptor and PD-L1 ligand must be prevented. Researchers have come up with the idea to extract T-cells from the patients body, and use CRISPR/Cas9 to "break" the DNA coding for the PD-1 protein. After this step, the T-cells will be reintroduced in the body, and hopefully attack the tumor without going into self-destruction mode. According to the journal Nature, the first patients will be treated as early as next month.

Risks


It is proven that CRISPR/Cas9 has to cope with off-target effects.. But since these are fully differentiated T-cells I do not expect that other DNA changes will pose a huge risk. But you never know.
Some other thing I was wondering about myself was whether there is an risk for autoimmune disease. I have not read the details of this study, but maybe someone at Steem has an idea?
Curing cancer is a clear case for the better of human kind. But as you can imagine CRISPR/Cas9 can be used for a lot more... What are your thoughts on genome engineering?

Some Links:


http://www.nature.com/news/chinese-scientists-to-pioneer-first-human-crispr-trial-1.20302
https://www.statnews.com/2016/07/21/crispr-experiment-humans/?s_campaign=stat:rss
https://www.statnews.com/2016/07/18/crispr-off-target-effects/?trendmd-shared=0

Sort:  

Congratulations @mjpdejong! You have received a personal award!

Happy Birthday - 1 Year
Click on the badge to view your own Board of Honor on SteemitBoard.

For more information about this award, click here

By upvoting this notification, you can help all Steemit users. Learn how here!

Congratulations @mjpdejong! You have received a personal award!

2 Years on Steemit
Click on the badge to view your Board of Honor.

Do not miss the last post from @steemitboard:
SteemitBoard World Cup Contest - Play-off for third result


Participate in the SteemitBoard World Cup Contest!
Collect World Cup badges and win free SBD
Support the Gold Sponsors of the contest: @good-karma and @lukestokes


Do you like SteemitBoard's project? Then Vote for its witness and get one more award!

Congratulations @mjpdejong! You received a personal award!

Happy Birthday! - You are on the Steem blockchain for 3 years!

You can view your badges on your Steem Board and compare to others on the Steem Ranking

Vote for @Steemitboard as a witness to get one more award and increased upvotes!

Hi! This post has a Flesch-Kincaid grade level of 7.0 and reading ease of 75%. This puts the writing level on par with Tom Clancy and F. Scott Fitzgerald.